110 related articles for article (PubMed ID: 7454449)
1. Nephrotic syndrome: increased platelet prostaglandin endoperoxide formation, hyperaggregability, and reduced platelet life span. Reversal following remission.
Stuart MJ; Spitzer RE; Nelson DA; Sills RH
Pediatr Res; 1980 Sep; 14(9):1078-81. PubMed ID: 7454449
[No Abstract] [Full Text] [Related]
2. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
[TBL] [Abstract][Full Text] [Related]
3. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H
Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902
[TBL] [Abstract][Full Text] [Related]
4. Coagulation and thromboembolic complications in the nephrotic syndrome.
Cameron JS
Adv Nephrol Necker Hosp; 1984; 13():75-114. PubMed ID: 6433673
[No Abstract] [Full Text] [Related]
5. [Platelet hyperaggregation and plasma hypercoagulability associated with normal antithrombin III and platelet factor 3 deficiency in the nephrotic syndrome in children].
Cutcudache C; Boldescu G; Antal C; Chirică A
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(1):57-66. PubMed ID: 6145206
[No Abstract] [Full Text] [Related]
6. [Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2].
Mazurov AB; Leĭtin VL; Repin VS
Biull Eksp Biol Med; 1984 Nov; 98(11):563-6. PubMed ID: 6439262
[TBL] [Abstract][Full Text] [Related]
7. [Ristocetin induced platelet aggregation in children with nephrotic syndrome].
Taira K; Okajima C; Yamashita T; Kawahara S; Matsunaga T; Nakajima M; Kamitsuji H
Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):659-66. PubMed ID: 2214316
[TBL] [Abstract][Full Text] [Related]
8. Abnormal platelet and vascular prostaglandin synthesis in an infant with hemolytic uremic syndrome.
Stuart MJ; Spitzer RE; Coppe D
Pediatrics; 1983 Jan; 71(1):120-4. PubMed ID: 6336835
[No Abstract] [Full Text] [Related]
9. [Changes in platelet sensitivity to thromboxane A2 in pediatric patients with nephrotic syndrome].
Watanabe M; Suzuki J; Suzuki H
Nihon Jinzo Gakkai Shi; 1996 Aug; 38(8):356-63. PubMed ID: 8828355
[TBL] [Abstract][Full Text] [Related]
10. Nephrotic syndrome: a platelet hyperaggregability state.
Rasedee A; Feldman BF
Vet Res Commun; 1985 Jul; 9(3):199-211. PubMed ID: 2930939
[TBL] [Abstract][Full Text] [Related]
11. Vitamin E and platelet function.
Stuart MJ; Oski FA
Am J Pediatr Hematol Oncol; 1979; 1(1):77-82. PubMed ID: 396795
[TBL] [Abstract][Full Text] [Related]
12. [Platelet function and antithrombin III levels in insulin-dependent juvenile diabetes].
Masperi R; Corbella E; di Natale B; Miragliotta G; Villa S
Minerva Dietol Gastroenterol; 1979; 25(3):315-8. PubMed ID: 554021
[No Abstract] [Full Text] [Related]
13. [Risk factors, atherosclerosis and thromboembolism in the nephrotic syndrome].
Previato G; Loschiavo C; Tessitore N; Chiaramonte S; Oldrizzi L; Lupo A; Valvo E; Maschio G; Saporiti E
Minerva Nefrol; 1981; 28(3):421-30. PubMed ID: 7036020
[No Abstract] [Full Text] [Related]
14. Hypoalbuminemia-related platelet hypersensitivity in two dogs with nephrotic syndrome.
Green RA; Russo EA; Greene RT; Kabel AL
J Am Vet Med Assoc; 1985 Mar; 186(5):485-8. PubMed ID: 2982777
[TBL] [Abstract][Full Text] [Related]
15. In vivo measurement of platelet activity in postoperative patients.
Stulberg BN; Weksler BB; Ranawat CS
Surg Forum; 1979; 30():489-91. PubMed ID: 538672
[No Abstract] [Full Text] [Related]
16. Arachidonic acid peroxidation, prostaglandin synthesis and platelet function.
Rao GH; Gerrard JM; Eaton JW; White JG
Photochem Photobiol; 1978; 28(4-5):845-50. PubMed ID: 733933
[No Abstract] [Full Text] [Related]
17. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
Smith JB; Ingerman CM; Silver MJ
J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
[TBL] [Abstract][Full Text] [Related]
18. Platelet hyperaggregability in the nephrotic syndrome which is not dependent on arachidonic acid metabolism or on plasma albumin concentration.
Bennett A; Cameron JS
Clin Nephrol; 1987 Apr; 27(4):182-8. PubMed ID: 3107859
[TBL] [Abstract][Full Text] [Related]
19. Pituitary adenylate cyclase-activating polypeptide deficiency associated with increased platelet count and aggregability in nephrotic syndrome.
Eneman B; Freson K; van den Heuvel L; van Hoyweghen E; Collard L; Vande Walle J; van Geet C; Levtchenko E
J Thromb Haemost; 2015 May; 13(5):755-67. PubMed ID: 25758343
[TBL] [Abstract][Full Text] [Related]
20. [Prophylactic use of concentrated antithrombin III preparation in children with nephrotic syndrome].
Oikawa T; Muramatsu Y; Akashi S; Usui N
Nihon Jinzo Gakkai Shi; 1993 Oct; 35(10):1163-9. PubMed ID: 8264106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
